ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

ONS To Fund 21 Grants In ’94 Deadline Dec. 1

June 11, 1993

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992